Valentine Capital Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Valentine Capital Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$988K	Sell	8,763 -1,275	-13%	-$138K	1.1%	40
2015 Q3	$1.01M	Sell	10,038 -4,125	-29%	-$495K	0.9%	44
2015 Q2	$1.74M	Sell	14,163 -15,675	-53%	-$1.88M	1.17%	38
2015 Q1	$3.42M	Sell	29,838 -7,005	-19%	-$773K	1%	42
2014 Q4	$3.73M	Sell	36,843 -11,055	-23%	-$1.07M	0.91%	49
2014 Q3	$4.37M	Sell	47,898 -1,455	-3%	-$128K	1.69%	29
2014 Q2	$4.23M	Sell	49,353 -9,795	-17%	-$772K	0.81%	65
2014 Q1	$4.66M	Buy	59,148 +23,538	+66%	+$1.96M	0.97%	45
2013 Q4	$2.69M	Buy	35,610 +1,845	+5%	+$131K	0.58%	64
2013 Q3	$2.36M	Sell	33,765 -330	-1%	-$21.6K	0.62%	58
2013 Q2	$1.98M	Buy	+34,095	New	+$1.97M	0.62%	59

Other funds holding IBB

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Valentine Capital Asset Management's IBB Position: Q4 2015 in Review

Valentine Capital Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 13% in Q4 2015, selling an estimated $138K and leaving 8,763 shares worth $988K. The position accounts for 1.1% of the portfolio, ranked #40.

Valentine Capital Asset Management first reported a position in IBB in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.66M in Q1 2014. 432 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

Valentine Capital Asset Management held 8,763 shares of iShares Biotechnology ETF worth $988K as of Q4 2015.
Valentine Capital Asset Management sold 1,275 iShares Biotechnology ETF shares in Q4 2015, an estimated $138K.
iShares Biotechnology ETF made up 1.1% of Valentine Capital Asset Management's portfolio in Q4 2015, its #40 holding.
Valentine Capital Asset Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 11 quarters since.
Valentine Capital Asset Management's iShares Biotechnology ETF position peaked at $4.66M in Q1 2014.
432 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.